4-6081618-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001099433.2(JAKMIP1):c.1092C>T(p.Asn364Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00278 in 1,614,090 control chromosomes in the GnomAD database, including 111 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.015 ( 58 hom., cov: 32)
Exomes 𝑓: 0.0015 ( 53 hom. )
Consequence
JAKMIP1
NM_001099433.2 synonymous
NM_001099433.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0160
Genes affected
JAKMIP1 (HGNC:26460): (janus kinase and microtubule interacting protein 1) Enables GABA receptor binding activity and RNA binding activity. Involved in cognition. Is extrinsic component of membrane. Part of ribonucleoprotein complex. [provided by Alliance of Genome Resources, Apr 2022]
C4orf50 (HGNC:33766): (chromosome 4 open reading frame 50)
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant 4-6081618-G-A is Benign according to our data. Variant chr4-6081618-G-A is described in ClinVar as [Benign]. Clinvar id is 783416.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.016 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0507 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
JAKMIP1 | NM_001099433.2 | c.1092C>T | p.Asn364Asn | synonymous_variant | 6/21 | ENST00000409021.9 | NP_001092903.1 | |
JAKMIP1 | NM_001306133.2 | c.1092C>T | p.Asn364Asn | synonymous_variant | 6/13 | NP_001293062.1 | ||
JAKMIP1 | NM_144720.4 | c.1092C>T | p.Asn364Asn | synonymous_variant | 6/13 | NP_653321.1 | ||
JAKMIP1 | NM_001306134.2 | c.597C>T | p.Asn199Asn | synonymous_variant | 5/12 | NP_001293063.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
JAKMIP1 | ENST00000409021.9 | c.1092C>T | p.Asn364Asn | synonymous_variant | 6/21 | 1 | NM_001099433.2 | ENSP00000386711.3 |
Frequencies
GnomAD3 genomes AF: 0.0150 AC: 2286AN: 152118Hom.: 58 Cov.: 32
GnomAD3 genomes
AF:
AC:
2286
AN:
152118
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00387 AC: 974AN: 251420Hom.: 23 AF XY: 0.00277 AC XY: 377AN XY: 135886
GnomAD3 exomes
AF:
AC:
974
AN:
251420
Hom.:
AF XY:
AC XY:
377
AN XY:
135886
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00151 AC: 2203AN: 1461854Hom.: 53 Cov.: 31 AF XY: 0.00130 AC XY: 949AN XY: 727226
GnomAD4 exome
AF:
AC:
2203
AN:
1461854
Hom.:
Cov.:
31
AF XY:
AC XY:
949
AN XY:
727226
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0150 AC: 2287AN: 152236Hom.: 58 Cov.: 32 AF XY: 0.0149 AC XY: 1107AN XY: 74440
GnomAD4 genome
AF:
AC:
2287
AN:
152236
Hom.:
Cov.:
32
AF XY:
AC XY:
1107
AN XY:
74440
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
8
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at